Ceremed, Inc.

Ceremed, Inc. is a privately held California corporation founded in 2002 by a group of experts in the fields of physiology, biophysics, chemistry, hematology, and reconstructive plastic surgery. The company specializes in implantable polymers and has established itself as a leader in developing next-generation medical products using proprietary polymer technology. Ceremed's strategic focus involves collaborating with leading universities and medical device/pharmaceutical manufacturers to create breakthrough products, allowing the company to concentrate on product development, clinical trials, strong intellectual property positions, and regulatory approvals. Ceremed's product portfolio includes Ostene®, Porous Polyethylene (PPE) Implants for reconstructive surgery, AOC PolymerBlend™ coatings, and AOC PolymerBlend™ carrier systems for bioactive ingredients. The company maintains substantial IP positions within the biocompatible polymer and device space, with numerous patents covering a wide variety of technologies and applications. As a manufacturing industry player headquartered in the United States, Ceremed is positioned as an innovator in developing medical solutions that leverage its expertise in polymer technology. Although specific details about the company's last investment and investors are not available, Ceremed's commitment to pioneering medical advancements through partnerships and proprietary technologies showcases its potential for investment and growth in the healthcare and biotechnology sectors.